Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 7Dermatologic 6Breast 6Sarcoma 5Gynecologic 5Genitourinary 5CNS 4Plasma cell 2Thoracic 1

Conditions

Hemangioma, Cavernous, Central Nervous System 2Spinal Cord Neoplasms 1Neuroblastoma 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Propranolol × CNS × Clear all
NCT02641314 2024-05-10

METRO-NB2012

University of Cologne

Phase 2 Completed
18 enrolled
CNS

Neuroblastoma

NCT03474614 2024-04-19

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

St. Joseph's Hospital and Medical Center, Phoenix

Phase 2 Terminated
4 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

NCT03589014 2022-02-25

Treat_CCM

Mario Negri Institute for Pharmacological Research

Phase 2 Completed
71 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

NCT05106179 2021-11-03

The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

Center for Vascular Pathology, Moscow

Phase 4 Unknown
1,000 enrolled
CNS

Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡